FAF
HZNP

Första AP-fonden’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Första AP-fonden’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42,400
Closed -$4.91M – 593
2023
Q3 		$4.91M Buy
42,400
+900
+2% +$96.7K 0.05% 348
2023
Q2 		$4.27M Sell
41,500
-1,100
-3% -$116K 0.05% 396
2023
Q1 		$4.65M Sell
42,600
-7,000
-14% -$774K 0.05% 366
2022
Q4 		$5.64M Buy
49,600
+8,000
+19% +$664K 0.06% 340
2022
Q3 		$2.58M Sell
41,600
-2,200
-5% -$154K 0.03% 477
2022
Q2 		$3.49M Buy
43,800
+6,100
+16% +$578K 0.05% 423
2022
Q1 		$3.97M Sell
37,700
-5,800
-13% -$565K 0.05% 424
2021
Q4 		$4.69M Buy
43,500
+2,400
+6% +$262K 0.05% 412
2021
Q3 		$4.5M Sell
41,100
-11,400
-22% -$1.18M 0.05% 415
2021
Q2 		$4.92M Buy
52,500
+5,500
+12% +$506K 0.06% 395
2021
Q1 		$4.33M Buy
47,000
+7,700
+20% +$650K 0.06% 386
2020
Q4 		$2.88M Buy
+39,300
New +$2.92M 0.04% 438

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Första AP-fonden's HZNP Position: Q4 2023 in Review

Första AP-fonden sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 42,400 shares — an estimated $4.91M sold.

Första AP-fonden first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $5.64M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Första AP-fonden reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Första AP-fonden sold 42,400 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.91M.
  • Första AP-fonden first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Första AP-fonden's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.64M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Första AP-fonden's 13F filing for Q4 2023, filed 6 Feb 2024.